Role of osteoprotegerin/receptor activator of nuclear factor kappa B/receptor activator of nuclear factor kappa B ligand axis in nonalcoholic fatty liver disease. (Q55167292)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Role of osteoprotegerin/receptor activator of nuclear factor kappa B/receptor activator of nuclear factor kappa B ligand axis in nonalcoholic fatty liver disease.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

23 June 2018

http://europepmc.org/abstract/PMC/5960813

7 references

19 March 2019

21 March 2019

24 March 2019

31 July 2019

20 November 2019

15 December 2019

28 October 2022

Role of osteoprotegerin/receptor activator of nuclear factor kappa B/receptor activator of nuclear factor kappa B ligand axis in nonalcoholic fatty liver disease. (English)

1 reference

Europe PubMed Central

23 June 2018

http://europepmc.org/abstract/PMC/5960813

metabolic dysfunction–associated steatotic liver disease

6 references

19 March 2019

21 March 2019

24 March 2019

31 July 2019

20 November 2019

15 December 2019

6 references

19 March 2019

21 March 2019

24 March 2019

31 July 2019

20 November 2019

15 December 2019

cell surface receptor

1 reference

31 July 2019

1 reference

20 November 2019

membrane proteins

1 reference

15 December 2019

author name string

Lucia Pacifico

1

1 reference

Europe PubMed Central

23 June 2018

http://europepmc.org/abstract/PMC/5960813

Gian Marco Andreoli

2

1 reference

Europe PubMed Central

23 June 2018

http://europepmc.org/abstract/PMC/5960813

Miriam D'Avanzo

3

1 reference

Europe PubMed Central

23 June 2018

http://europepmc.org/abstract/PMC/5960813

Delia De Mitri

4

1 reference

Europe PubMed Central

23 June 2018

http://europepmc.org/abstract/PMC/5960813

Pasquale Pierimarchi

5

1 reference

Europe PubMed Central

23 June 2018

http://europepmc.org/abstract/PMC/5960813

language of work or name

0 references

publication date

1 May 2018

1 reference

Europe PubMed Central

23 June 2018

http://europepmc.org/abstract/PMC/5960813

21 May 2018

7 references

19 March 2019

21 March 2019

24 March 2019

31 July 2019

20 November 2019

15 December 2019

28 October 2022

World Journal of Gastroenterology

8 references

Europe PubMed Central

23 June 2018

http://europepmc.org/abstract/PMC/5960813

19 March 2019

21 March 2019

24 March 2019

31 July 2019

20 November 2019

15 December 2019

28 October 2022

24

1 reference

Europe PubMed Central

23 June 2018

http://europepmc.org/abstract/PMC/5960813

2073-2082

1 reference

Europe PubMed Central

23 June 2018

http://europepmc.org/abstract/PMC/5960813

19

1 reference

Europe PubMed Central

23 June 2018

http://europepmc.org/abstract/PMC/5960813

copyright license

Creative Commons Attribution-NonCommercial 4.0 International

7 references

Europe PubMed Central

19 March 2019

Europe PubMed Central

21 March 2019

Europe PubMed Central

24 March 2019

Europe PubMed Central

31 July 2019

Europe PubMed Central

20 November 2019

Europe PubMed Central

15 December 2019

Europe PubMed Central

28 October 2022

on focus list of Wikimedia project

0 references

Non-alcoholic fatty liver disease connections with fat-free tissues: A focus on bone and skeletal muscle

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

High BMI in late adolescence predicts future severe liver disease and hepatocellular carcinoma: a national, population-based cohort study in 1.2 million men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Serum Osteoprotegerin Is a Potential Biomarker of Insulin Resistance in Chinese Postmenopausal Women with Prediabetes and Type 2 Diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Association of Osteoprotegerin with Obesity, Insulin Resistance and Non-Alcoholic Fatty Liver Disease in Children.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

The Impact of Nonalcoholic Fatty Liver Disease on Renal Function in Children with Overweight/Obesity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Osteoprotegerin levels are associated with liver fat and liver markers in dysmetabolic adults.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Plasma osteoprotegerin levels are inversely associated with nonalcoholic fatty liver disease in patients with type 2 diabetes: A case-control study in China

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Association of osteoprotegerin with impaired glucose regulation and microalbuminuria: the REACTION study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Combined Serum Biomarkers in Non-Invasive Diagnosis of Non-Alcoholic Steatohepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Osteoprotegerin in Cardiometabolic Disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Osteoprotegerin in relation to insulin resistance and blood lipids in sub-Saharan African women with and without abdominal obesity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

NAFLD: a multisystem disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Nonalcoholic fatty liver disease and the heart in children and adolescents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

OPG/RANKL/RANK axis is a critical inflammatory signaling system in ischemic brain in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Osteoprotegerin in cardiovascular disease: ally or enemy?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Adipokines and C-reactive protein in relation to bone mineralization in pediatric nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

TRAF molecules in cell signaling and in human diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

The role of osteoprotegerin in cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Review article: non-alcoholic fatty liver disease and osteoporosis--clinical and molecular crosstalk.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Non-alcoholic fatty liver disease is associated with low bone mineral density in obese children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Association of serum osteoprotegerin with left ventricular mass in African American adults with hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Osteoprotegerin in relation to type 2 diabetes mellitus and the metabolic syndrome in postmenopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

RANK/RANKL: regulators of immune responses and bone physiology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Causes and metabolic consequences of Fatty liver

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Pathophysiological roles of osteoprotegerin (OPG).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Functions of RANKL/RANK/OPG in bone modeling and remodeling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Expression and regulation of osteoprotegerin in adipose tissue

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

RANKL, RANK, osteoprotegerin: key partners of osteoimmunology and vascular diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Insulin attenuates vascular smooth muscle calcification but increases vascular smooth muscle cell phosphate transport

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Apoptosis in alcoholic and nonalcoholic steatohepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

An integrated physical map of 8q22-q24: use in positional cloning and deletion analysis of Langer-Giedion syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

A novel molecular mechanism modulating osteoclast differentiation and function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Characterization of structural domains of human osteoclastogenesis inhibitory factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

24 June 2018

Childhood obesity: A growing concern.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

13 August 2018

The potential role of the osteopontin-osteocalcin-osteoprotegerin triad in the pathogenesis of prediabetes in humans.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

13 August 2018

The role of osteoprotegerin in the crosstalk between vessels and bone: Its potential utility as a marker of cardiometabolic diseases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

13 August 2018

Circulating osteoprotegerin in postmenopausal osteoporotic women: marker of impaired glucose regulation or impaired bone metabolism.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

13 August 2018

Relationship between insulin resistance, hs-CRP, and body fat and serum osteoprotegerin/RANKL in prediabetic patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

13 August 2018

Wnt/β-catenin signaling in osteoblasts regulates global energy metabolism.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

13 August 2018

Cardiac hypertrophy is exacerbated in aged mice lacking the osteoprotegerin gene.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

13 August 2018

Osteoprotegerin is independently associated with metabolic syndrome and microvascular complications in type 2 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

13 August 2018

Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

13 August 2018

The relation between carotid intima media thickness and serum osteoprotegerin levels in nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

13 August 2018

The association of insulin resistance with serum osteoprotegerin in obese adolescents.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

13 August 2018

A comparison of osteoprotegerin with adiponectin and high-sensitivity C-reactive protein (hsCRP) as a marker for insulin resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

13 August 2018

Similar to adiponectin, serum levels of osteoprotegerin are associated with obesity in healthy subjects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

13 August 2018

Circulating osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in polycystic ovary syndrome: relationships to insulin resistance and endothelial dysfunction.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

13 August 2018

Increased osteoprotegerin levels in women with previous gestational diabetes developing metabolic syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

13 August 2018

Serum osteoprotegerin is associated with carotid intima media thickness in women with previous gestational diabetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

13 August 2018

Osteoprotegerin decreases human osteoclast apoptosis by inhibiting the TRAIL pathway.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

13 August 2018

Osteoprotegerin in relation to body weight, lipid parameters insulin sensitivity, adipocytokines, and C-reactive protein in obese and non-obese young individuals: results from both cross-sectional and interventional study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

13 August 2018

Determinants of endothelial function in a cohort of patients with peripheral artery disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

13 August 2018

Circulating leptin and osteoprotegerin levels affect insulin resistance in healthy premenopausal obese women.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

13 August 2018

Plasma osteoprotegerin levels in the general population: relation to indices of left ventricular structure and function.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

13 August 2018

Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

13 August 2018

The relationship between insulin resistance assessed by HOMA-IR and serum osteoprotegerin levels in obesity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

13 August 2018

Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

13 August 2018

Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

13 August 2018

Receptor activator of NF-kappa B ligand and osteoprotegerin regulate proinflammatory cytokine production in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

2 November 2018

Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5960813

30 November 2018

Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in Mönckeberg's sclerosis and atherosclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/29785076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of a serum assay for quantification of abdominal aortic calcification

1 reference

https://pubmed.ncbi.nlm.nih.gov/29785076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Calcification of human vascular smooth muscle cells: associations with osteoprotegerin expression and acceleration by high-dose insulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/29785076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/29785076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship of elevated osteoprotegerin with insulin resistance, CRP, and TNF-alpha levels in men with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/29785076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum levels of osteoprotegerin in the spectrum of nonalcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/29785076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of RANKL on the thymic medulla

1 reference

https://pubmed.ncbi.nlm.nih.gov/29785076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating osteoprotegerin is increased in the metabolic syndrome and associates with subclinical atherosclerosis and coronary arterial calcification

1 reference

https://pubmed.ncbi.nlm.nih.gov/29785076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trends in Obesity and Severe Obesity Prevalence in US Youth and Adults by Sex and Age, 2007-2008 to 2015-2016

1 reference

https://pubmed.ncbi.nlm.nih.gov/29785076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3748/WJG.V24.I19.2073

1 reference

Europe PubMed Central

23 June 2018

http://europepmc.org/abstract/PMC/5960813

1 reference

Europe PubMed Central

23 June 2018

http://europepmc.org/abstract/PMC/5960813

1 reference

Europe PubMed Central

23 June 2018

http://europepmc.org/abstract/PMC/5960813

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55167292&oldid=1760025949"